Board Meetings for NATCOPHARM
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| NATCOPHARM | Natco Pharma Limited | 12 Nov 2024 | Financial Results/Dividend | To consider and approve the un audited financial results for the period ended September 30, 2024 and 2nd Interim dividend, if any | |
| NATCOPHARM | Natco Pharma Limited | 12 Aug 2024 | NATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and Dividend. | Board Meeting Intimation | |
| NATCOPHARM | Natco Pharma Limited | 12 Aug 2024 | Financial Results/Dividend | To consider and approve the financial results for the quarter ended Jun 30, 2024 and Interim dividend for FY 2024-25, if any | |
| NATCOPHARM | Natco Pharma Limited | 27 May 2024 | NATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 27-May-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2024 . | Board Meeting Intimation | |
| NATCOPHARM | Natco Pharma Limited | 27 May 2024 | Financial Results | To consider and approve the financial results for the period ended March 31, 2024 | |
| NATCOPHARM | Natco Pharma Limited | 14 Feb 2024 | NATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2023 and Dividend. | Board Meeting Intimation | |
| NATCOPHARM | Natco Pharma Limited | 14 Feb 2024 | Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2023 and 3rd interim dividend for the Financial Year 2023-24, if any. | |
| NATCOPHARM | Natco Pharma Limited | 14 Nov 2023 | Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2023 and Interim dividend, if any | |
| NATCOPHARM | Natco Pharma Limited | 14 Nov 2023 | NATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2023 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2023 and Dividend. | Board Meeting Intimation | |
| NATCOPHARM | Natco Pharma Limited | 09 Aug 2023 | NATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 09-Aug-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2023 and Dividend. | Board Meeting Intimation | |
| NATCOPHARM | Natco Pharma Limited | 09 Aug 2023 | Financial Results/Dividend | To consider and approve the unaudited financial results for the period ended Jun 30, 2023 and interim dividend for the financial year ending 2023-24 | |
| NATCOPHARM | Natco Pharma Limited | 29 May 2023 | Financial Results | To consider and approve the financial results for the period ended March 31, 2023 | |
| NATCOPHARM | Natco Pharma Limited | 29 May 2023 | NATCO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2023 . | Board Meeting Intimation | |
| NATCOPHARM | Natco Pharma Limited | 08 Mar 2023 | Buyback | To consider buyback for equity shares | |
| NATCOPHARM | Natco Pharma Limited | 09 Feb 2023 | Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2022 and to consider the third interim dividend, if any |